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A B S T R A C T  
Background: Diabetic foot infections are a common cause of morbidity in type 1 & 2 Diabetes mellitus. The selection of 
appropriate empirical treatment is thus essential while treating such patients. The main objective of this study was to find out most 
prevalent bacteria and their sensitivity to various antibiotics in patients with diabetic foot infections. 
Material and Methods: This cross-sectional study was conducted in the Department of Surgery, Pakistan Institute of Medical 
Sciences (PIMS), Islamabad from January 2017 to December 2017. A total 118 patients were included through consecutive 
sampling technique. Samples were collected in the form of swab, pus or tissue material and were cultured on blood agar and 
microorganisms were identified using standard microbiological methods. Antimicrobial sensitivity was also checked. Statistical 
Package for Social Sciences (SPSS) version 22 was used to analyze data. 
Results: Out of 118 patients, 72% (n=85) were males while 28% (n=33) were females. Cultures of 105 patients were positive and 
most common organisms isolated were S. aureus (32.4%; n=34), E. coli (17.1%; n=18), P. aeruginosa (14.3%; n=15), Polymicrobials 
(14.3%; n=15) and K. pneumoniae (7.6%; n=8). Antibiotics to which organisms were most sensitive included Piperacillin/Tazobactam 
(69.5%; n=73), Imipenem (55.2%; n=58), Amikacin (43.8%; n=46), Vancomycin (40%; n=42) and Levofloxacin (38.1%; n=40). 
Conclusion: Most common organisms causing diabetic foot infections in our study were S. aureus, E. coli, P. aeruginosa, 
Polymicrobial and Klebsiella. Overall most sensitive antibiotics to these organisms included Piperacillin/Tazobactam, Imipenem, 
Amikacin, Vancomycin and Levofloxacin. 
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I n t r o d u c t i o n  
 
The average worldwide prevalence of type 2 Diabetes 
Mellitus in adults is 6.4 %. It ranges from 3.8 to 10.2% 
among different regions of Pakistan. Rates of 
undiagnosed diabetes may be as high as 50% in some 
areas.1 Incidence of Type 1 Diabetes Mellitus also vary 
worldwide with highest reported incidence in Finland and 
Sardinia (37- 65 per 100,000) and lowest in China and 
Venezuela (0.1-1.9 per 100,000).2,3 Foot related problems 
are an important cause of morbidity in patients with 
diabetes mellitus. Lifetime risk of foot ulcers for diabetic 
patients (type 1 or 2) may be as high as 25%.4 
Neuropathy, peripheral vascular disease (PVD) and poor 
glycemic control are among the important risk factors 
responsible for development of diabetic foot infection.5 
ORIGINAL ARTICLE 
                           J Islamabad Med Dental Coll 2019 9 
Sensory neuropathy causes diminished perception of pain 
and temperature that leads to poor recognition of injury to 
the feet. Autonomic neuropathy causes reduced sweat 
secretion resulting in dry, cracked skin that facilitates the 
entry of microorganisms. Motor neuropathy leads to foot 
deformities leading to pressure induced soft tissue 
damage. Most of the diabetic foot infections are 
polymicrobial and are variable depending on the extent of 
involvement.5  
 
Host defense and neutrophil functions are impaired by 
hyperglycemia. Trauma in patients with one or more of 
these risk factors precipitate development of wounds that 
are slow to heal and predispose to secondary infection. 
Three key steps involved in evaluation of a patient with 
diabetic foot infection are: 1) identification of risk factors, 
2) determination of extent and severity of infection and 3) 
assessment of microbial etiology.5 For preventive and 
monitoring strategies, certain risk categorization systems 
can be used. One such system is developed by 
International Working Group on the Diabetic Foot that 
stratifies patients as follows:6 0) No evidence of 
neuropathy, 1) neuropathy present but no evidence of 
foot deformity or PVD, 2) neuropathy with evidence of 
deformity or PVD, 3) history of foot ulceration or lower 
extremity amputation. At least 2 of the following i.e. 
erythema, warmth, tenderness or swelling should be 
present to make a presumptive diagnosis of diabetic foot 
infection. Osteomyelitis is likely to be present if bone can 
be seen at the floor of deep ulcer.7 Aerobic gram-positive 
cocci which include Staphylococcus aureus (S. aureus), 
Streptococcus agalactiae (S. agalactiae), Streptococcus 
pyogenes (S. pyogenes) and coagulase negative 
staphylococci are mostly responsible for superficial 
diabetic foot infections (cellulitis and infected ulcers in 
antibiotic-naive patients).8 
 
Deep and chronically infected ulcers and those that are 
previously treated with antibiotics, are more likely to be 
polymicrobial and in addition to above mentioned 
microorganisms; involve Enterococci, Enterobacteriaceae, 
Pseudomonas aeruginosa (P. aeruginosa), and 
anaerobes.8 Wounds with extensive local inflammation, 
necrosis, malodorous drainage, necrosis, or gangrene 
with signs of systemic toxicity should be presumed to 
have anaerobic organisms in addition to the above 
pathogens.8 Microbiological spectrum also differs by 
geographic location; with gram-negative pathogens 
predominating in the sub-tropical climates of Africa and 
Asia, in contrast to gram-positive organisms in the 
western parts of the world.9 Current study is aimed at 
identifying the common pathogens involved in diabetic 
foot infections in our set-up and their susceptibility to 
commonly used antimicrobial therapy that may guide in 
selection of effective empiric treatment. 
 
M a t e r i a l  a n d  M e t h o d s  
This was a cross sectional study, conducted in the 
Department of Surgery, Pakistan Institute of Medical 
Sciences (PIMS), Islamabad. Duration of study was one 
year, from January 2017 to December 2017. Patients, 
presenting in the outpatient department, emergency or 
ward, qualifying the criteria of PEDIS (Perfusion, Extent, 
Depth, Infection and Sensation) system of diabetic foot 
classification were included in the study.10 This study was 
approved by the ethics committee of the hospital and 
written informed consent was obtained from all the 
patients prior to enrolment in this study. A total of 118 
patients presenting with signs and symptoms suggestive 
of Diabetic Foot Infection were included in this study 
through consecutive sampling technique.  
 
Sample size was calculated through WHO sample size 
calculator by using 95% confidence interval, 80% power 
of study and 7.4% prevalence of diabetic foot ulcer in 
Pakistan.11 Calculated sample size was 106 diabetic 
patients. In order to overcome the possibility of dropouts, 
total 118 patients were included in the study. Collected 
samples included swabs, pus and tissue material after 
cleansing with non-antimicrobial substance. At the time of 
sample collection, no patient was on antimicrobial 
therapy. Samples were sent promptly to microbiology 
laboratory where they were cultured on blood agar and 
MacConkey agar plates. Organisms were further 
identified using respective biochemical tests according to 
standard microbiological protocols. Bacteria that were 
cultured included S. aureus, E. coli, P. aeruginosa, 
Proteus, Klebsiella pneumoniae, methicillin resistant S. 
aureus, Staphylococcus epidermidis, Acinetobacter, S. 
viridans and Enterobacter. A Polymicrobial group was 
added when culture was positive for two or more 
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organisms. Isolates were tested for susceptibility to 
commonly used antimicrobial therapy. Antibiotics that 
were included in culture sensitivity included 
Piperacillin/Tazobactam, Linezolid, Ceftriaxone, 
Vancomycin, Imipenem, Meropenem, Levofloxacin, Co-
Amoxiclav, Cefoperazone /Sulbactam, Amikacin, 
Clindamycin, Ceftazidime, Ciprofloxacin, Tigecycline, 
Chloremphenicol, Tobramycin and Cefoxitin. Statistical 
Package for Social Sciences (SPSS) version 22 was used 
to analyze data. The categorical data is presented in 
frequencies and percentages i.e. gender frequency, most 
common organisms and most sensitive antibiotics. 
 
R e s u l t s  
A total of 118 patients were included in this study with a 
mean age of 53 ± 9.8 years. Out of 118 patients, 85 were 
males (72%), and 33 were females (28%). About 105 
patients (89%) tested positive for bacterial growth, while 
13 patients (11%) had no organism growth on culture. Of 
the culture positive patients, 71.4% were males and 
28.6% were females. Cultured organisms were divided 
into 11 groups. First five organisms isolated in 105 culture 
positive patients in descending order were, S. aureus 
(32.4%; n=34), E. coli (17.1%; n=18), P. aeruginosa 
(14.3%; n=15), Polymicrobial (14.3%; n=15) and K. 
pneumoniae (7.6%; n=8) (Table I). Top five antibiotics to 
which organisms were sensitive in descending order were 
Piperacillin/Tazobactam (69.5%), Imipenem (55.2%), 
Amikacin (43.8%), Vancomycin (40%) and Levofloxacin 
(38.1%) (Table II).  
 
Table I: Frequency and Percentage of organisms isolated in 
culture positive patients (n=105) 
Sr. 
No 
Organism Frequency Percentage 
1 Staphylococcus aureus 34 32.4% 
2 Escherchia coli 18 17.1% 
3 Pseudomonas aeruginosa 15 14.3% 
4 Polymicrobial 15 14.3% 
5 Klebsiella pneumoniae 8 7.6% 
6 Proteus 5 4.8% 
7 Methicillin resistant 
staphylococcus aureus 
3 2.9% 
8 Staphylococcus epidermidis 3 2.9% 
9 Acinitobacter 2 1.9% 
10 Streptococcus viridans 1 1% 
11 Enterobacter 1 1% 
 
On an individual basis, S. aureus (n=34) was most 
sensitive to vancomycin (61.8%; n=21), E. coli (n=18) was 
most sensitive to Piperacillin/Tazobactam (88.9%; n=16), 
P. aeruginosa (n=15) was most sensitive to 
Piperacillin/Tazobactam (100%; n=15), Polymicrobial 
(n=15) was most sensitive to Piperacillin/Tazobactam and 
Amikacin (60%; n=9) and K. pneumoniae (n=8) was most 
sensitive to Piperacillin/Tazobactam (75%; n=6) (Table 
III). 
 
Table II: Frequency and Percentage of antibiotic sensitivity 
against organisms isolated (n=105) 
Sr No Antibiotic Frequency Percentage 
1 Piperacillin/Tazobactam 73 69.5% 
2 Imipenem 58 55.2% 
3 Amikacin 46 43.8% 
4 Vancomycin 42 40% 
5 Levoflaxacin 40 38.1% 
6 Cefoperazone/Sulbactam 34 32.4% 
7 Co-amoxiclav 33 31.4% 
8 Ceftriaxone 22 21% 
9 Linezolid 16 15.3% 
10 Meropenem 16 15.3% 
11 Tobramycin 13 12.4% 
12 Ciprofloxacin 6 5.7% 
13 Tigecycline 5 4.8% 
14 Clindamycin 4 3.8% 
15 Chloremphenicol 4 3.8% 
16 Ceftazidime 2 1.8% 
17 Cefoxitin 1 1% 
 
 
D i s c u s s i o n  
Our study shows that there is a male predominance in 
patients of diabetic foot with male to female ratio of 2.5:1. 
Other studies carried out in Pakistan either show higher 
male predominance of 4:1 for diabetic patients at Nishtar 
Hospital, Multan 12 and CMH Peshawar,13 or comparable 
ratio of 2.3:1.14 Male predominance can be due to males 
working outdoors exposed to contaminated surroundings 
compared to females performing household chores. 
Moreover, females in general are more concerned about 
their health and adopt preventive strategies. Our study 
shows mean age of 53 ± 9.8 years, which is in agreement 
to a study done on 73 patients in Karachi with a mean 
age of 52.7 ± 9.4 years.15 According to another study 
carried out in Nishtar Hospital Multan, the most commonly 
affected age group was also 50 to 60 years.12 The logical 
explanation for affecting older individuals is that Diabetes 
is usually diagnosed at a later age with multiple
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Table III: Top five common organisms and their sensitivity to different antibiotics 
Sr 
No 










1 Piperacillin/ Tazobactam 55.9% (n=19) 88.9% (n=16) 100% (n=15) 60% (n=9) 75% (n=6) 
2 Imipenem 52.9% (n=18) 66.7% (n=12) 80% (n=12) 40% (n=6) 37.5% (n=3) 
3 Amikacin 26.5% (n=9) 44.4% (n=8) 40% (n=6) 60% (n=9) 75% (n=6) 
4 Vancomycin 61.8% (n=21) 22.2% (n=4) 33.3% (n=5) 26.7% (n=4) 12.5% (n=1) 
5 Levoflaxacin 50% (n=17) 27.8% (n=5) 46.7% (n=7) 6.7% (n=1) 12.5% (n=1) 
  
co-morbidities, poor diabetic control and nutritional 
deficiencies. The most common groups of organisms 
identified in this study are S. aureus, E. coli, P. 
Aeruginosa and Polymicrobial. This was also seen in a 
study done in Khyber Pakhtunkhwa where S. aureus and 
E. coli were the most common organisms in diabetic foot 
patients.16 In another study Staphylococcus aureus was 
the most prevalent organism constituting 23.16% of the 
organisms isolated followed by Escherichia coli (17.89%) 
and Klebsiella (12.63%).15 Proteus, S. aureus, Klebsiella 
and P. aeruginosa were the most widely recognized 
microorganisms of diabetic foot infections.17 Another 
study showed S. aureus being the most commonly 
isolated organism.18,19 Our findings are comparable with 
other studies conducted in this region. In our study, 
organisms are most sensitive to Piperacillin/Tazobactam, 
Imipenem, Amikacin, Vancomycin and Levofloxacin. In a 
study on diabetic foot ulcers in Jinnah Postgraduate 
Medical Center, Karachi organisms were most sensitive to 
Meropenem, effective in 95% patients.15  
 
The specific antibiotic given against culture sensitive 
organisms helps in prevention of drug resistance, more 
accurate management and speedy recovery rather than 
empirical therapy. So, each organism being more 
sensitive to specific antibiotic should be treated with 
antibiotic of choice accordingly. Culture sensitivity should 
be done regularly to identify the organism and start proper 
antibiotic regimen. Hospital based studies can also help in 
maintaining an antibiogram, which should be periodically 
updated for devising antibiotic protocols for effective 







C o n c l u s i o n  
Diabetic foot infections are common in older age group 
with male predominance. Most common infecting 
organisms included S. aureus, E. coli, P. aeruginosa, 
Polymicrobial and Klebsiella with Piperacillin/ 
Tazobactam, Imepenem, Amikacin, Vancomycin and 
Levofloxacin emerging as the most sensitive antibiotics in 
our diabetic patients.  
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